157 related articles for article (PubMed ID: 38374399)
61. VAV2 regulates epidermal growth factor receptor endocytosis and degradation.
Thalappilly S; Soubeyran P; Iovanna JL; Dusetti NJ
Oncogene; 2010 Apr; 29(17):2528-39. PubMed ID: 20140013
[TBL] [Abstract][Full Text] [Related]
62. Exosome-mediated long noncoding RNA (lncRNA) PART1 suppresses malignant progression of oral squamous cell carcinoma via miR-17-5p/SOCS6 axis.
Du Y; Shuai Y; Wang H; Li H; Li Y
Turk J Med Sci; 2023 Jun; 53(3):630-639. PubMed ID: 37476905
[TBL] [Abstract][Full Text] [Related]
63. STAT3 and Its Targeting Inhibitors in Oral Squamous Cell Carcinoma.
Jiang M; Li B
Cells; 2022 Oct; 11(19):. PubMed ID: 36231093
[TBL] [Abstract][Full Text] [Related]
64. Long non-coding RNA CEBPA-AS1 correlates with poor prognosis and promotes tumorigenesis via CEBPA/Bcl2 in oral squamous cell carcinoma.
Guo Y; Ma Y; Hu X; Song R; Zhu L; Zhong M
Cancer Biol Ther; 2018 Mar; 19(3):205-213. PubMed ID: 29281558
[TBL] [Abstract][Full Text] [Related]
65. SNHG17/miR-384/ELF1 axis promotes cell growth by transcriptional regulation of CTNNB1 to activate Wnt/β-catenin pathway in oral squamous cell carcinoma.
Qiao C; Qiao T; Yang S; Liu L; Zheng M
Cancer Gene Ther; 2022 Jan; 29(1):122-132. PubMed ID: 33531646
[TBL] [Abstract][Full Text] [Related]
66. HEATR1, a novel interactor of Pontin/Reptin, stabilizes Pontin/Reptin and promotes cell proliferation of oral squamous cell carcinoma.
Nakamura A; Kakihara Y; Funayama A; Haga K; Mikami T; Kobayashi D; Yoshida Y; Izumi K; Kobayashi T; Saeki M
Biochem Biophys Res Commun; 2021 Jun; 557():294-301. PubMed ID: 33894417
[TBL] [Abstract][Full Text] [Related]
67. Receptor for activated C kinase 1 (RACK1) promotes the progression of OSCC via the AKT/mTOR pathway.
Zhang X; Liu N; Ma D; Liu L; Jiang L; Zhou Y; Zeng X; Li J; Chen Q
Int J Oncol; 2016 Aug; 49(2):539-48. PubMed ID: 27279145
[TBL] [Abstract][Full Text] [Related]
68. Exosomal miR-146b-5p derived from cancer-associated fibroblasts promotes progression of oral squamous cell carcinoma by downregulating HIPK3.
He L; Guo J; Fan Z; Yang S; Zhang C; Cheng B; Xia J
Cell Signal; 2023 Jun; 106():110635. PubMed ID: 36813147
[TBL] [Abstract][Full Text] [Related]
69. Circ_0058063 Contributed to Oral Squamous Cell Carcinoma Development by Sponging miR-145 and Regulating PI3K/AKT Pathway.
Zhou J; Jin S
Mol Biotechnol; 2023 Dec; 65(12):2049-2060. PubMed ID: 36928742
[TBL] [Abstract][Full Text] [Related]
70. RNAi-mediated downregulation of oral cancer overexpressed 1 (ORAOV1) inhibits vascular endothelial cell proliferation, migration, invasion, and tube formation.
Zhao X; Liu D; Wang L; Wu R; Zeng X; Dan H; Ji N; Jiang L; Zhou Y; Chen Q
J Oral Pathol Med; 2016 Apr; 45(4):256-61. PubMed ID: 26449957
[TBL] [Abstract][Full Text] [Related]
71. Down-regulation of lncRNA HCG11 promotes cell proliferation of oral squamous cell carcinoma through sponging miR-455-5p.
Wu J; Li Y; Liu J; Xu Y
J Gene Med; 2021 Mar; 23(3):e3293. PubMed ID: 33151000
[TBL] [Abstract][Full Text] [Related]
72. Abnormal downregulation of 10-formyltetrahydrofolate dehydrogenase promotes the progression of oral squamous cell carcinoma by activating PI3K/Akt/Rb pathway.
Qu Y; He Y; Ruan H; Qin L; Han Z
Cancer Med; 2023 Mar; 12(5):5781-5797. PubMed ID: 36336972
[TBL] [Abstract][Full Text] [Related]
73. Tumor Promoting Role of NRIP1 in Oral Squamous Cell Carcinoma: The Involvement of NSD2-Mediated Histone Methylation of DGCR8.
Zhang L; Hu G
Tohoku J Exp Med; 2023 Jul; 260(3):193-204. PubMed ID: 37045786
[TBL] [Abstract][Full Text] [Related]
74. Hippo-YAP signaling activation and cross-talk with PI3K in oral cancer: A retrospective cohort study.
Rodrigo JP; Rodríguez-Santamarta T; Corte D; García-de-la-Fuente V; Rodríguez-Torres N; Lequerica-Fernández P; Lorz C; García-Pedrero JM; de Vicente JC
Oral Dis; 2024 Mar; 30(2):149-162. PubMed ID: 35951471
[TBL] [Abstract][Full Text] [Related]
75. PAICS/DYRK3 Multienzyme Interactions as Coregulators of Purinosome Formation and Metabolism on Radioresistance in Oral Squamous Cell Carcinoma.
Huang CS; Hsieh MS; Yadav VK; Wu YC; Liu SC; Yeh CT; Huang MS
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139175
[TBL] [Abstract][Full Text] [Related]
76. Interplay between cancer cells and M2 macrophages is necessary for miR-550a-3-5p down-regulation-mediated HPV-positive OSCC progression.
Cao MX; Zhang WL; Yu XH; Wu JS; Qiao XW; Huang MC; Wang K; Wu JB; Tang YJ; Jiang J; Liang XH; Tang YL
J Exp Clin Cancer Res; 2020 Jun; 39(1):102. PubMed ID: 32493454
[TBL] [Abstract][Full Text] [Related]
77. Knockdown of lncRNA LEF1-AS1 inhibited the progression of oral squamous cell carcinoma (OSCC) via Hippo signaling pathway.
Zhang C; Bao C; Zhang X; Lin X; Pan D; Chen Y
Cancer Biol Ther; 2019; 20(9):1213-1222. PubMed ID: 30983488
[TBL] [Abstract][Full Text] [Related]
78. NFE2L1 restrains ferroptosis by transcriptionally regulating HJURP and participates in the progress of oral squamous cell carcinoma.
Zhang M; Wang Z; Yang G; Han L; Wang X
J Bioenerg Biomembr; 2023 Dec; 55(6):467-478. PubMed ID: 37848756
[TBL] [Abstract][Full Text] [Related]
79. Clinical significance of L1CAM expression and its biological role in the progression of oral squamous cell carcinoma.
Kim JH; Lee KW; Ahn DG; Oh KY; Yoon HJ
Oncol Rep; 2023 Apr; 49(4):. PubMed ID: 36825596
[TBL] [Abstract][Full Text] [Related]
80. Ephrin-B2 reverse signaling regulates progression and lymph node metastasis of oral squamous cell carcinoma.
Sasabe E; Tomomura A; Tomita R; Sento S; Kitamura N; Yamamoto T
PLoS One; 2017; 12(11):e0188965. PubMed ID: 29190834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
